Diabetes Medications

Diabetes Medications
Commonly Used Diabetes Medications

Metformin
Metformin is a well-studied, generic drug, used by millions of people around the world.

Insulin
Insulin is a hormone made by the pancreas that faciliates glucose uptake into the body's cells. Most insulin is taken by injection or through a pump.

SGLT-2 Inhibitors
SGLT-2 inhibitors are a type of oral medication that people with type 2 diabetes can use to lower blood sugar levels.

GLP-1 Receptor Agonists and Other Drugs
Here’s everything you need to know about GLP-1 medications like Ozempic, including benefits, side effects, and how to navigate your options.

DPP-4 Inhibitors
DPP-4 inhibitors are a type of medication that people with type 2 diabetes can use to lower blood sugar levels.

Glucagon
Glucagon is used to treat dangerously low blood sugar. Newer ready-to-use glucagon options offer more convenience for people with diabetes.
Latest Stories About Diabetes Medications
See All Diabetes Medications News
Tzield (Teplizumab) to Delay Type 1 Diabetes
Tzield has been shown to delay the onset of type 1 diabetes by an average of two years. Here’s more about screening and whether treatment may be right for you.
Survodutide Shows Promising Weight Loss and Cardiometabolic Benefits
Survodutide is a new investigational dual GLP-1 injectable medication being tested for weight management in clinical trials.
New Drug Retatrutide Shows Benefits for Diabetes and Weight Loss
Results from recent clinical trials suggest that retatrutide, a first-of-its-kind experimental drug, causes unprecedented levels of weight loss. Its effects on blood sugar for diabetes are comparable to currently available GLP-1 drugs like Ozempic.
First Expert Recommendations for Safe GLP-1 Use in Type 1 Diabetes
Off-label use of medications like Ozempic, Wegovy, Mounjaro, and Zepbound is becoming increasingly common to address weight management, insulin resistance, and diabetes related complications in type 1 diabetes. New expert recommendations provide a framework for safe use while large trials are ongoing.


